Teva Pays $450M To Resolve Alleged Kickback, Price-Fixing Schemes

Teva Pharmaceuticals has settled a $450 million case with the U.S. government for violating the Anti-Kickback Statute and False Claims Act. The settlement involves two kickback schemes and includes $225 million in criminal penalties paid earlier.